GenoFocus Inc (187420) - Total Liabilities

Latest as of March 2026: ₩82.66 Billion KRW ≈ $56.02 Million USD

Based on the latest financial reports, GenoFocus Inc (187420) has total liabilities worth ₩82.66 Billion KRW (≈ $56.02 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GenoFocus Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

GenoFocus Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how GenoFocus Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 187420 total asset value.

GenoFocus Inc Competitors by Total Liabilities

The table below lists competitors of GenoFocus Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Sunfar Computer Co Ltd TWO:6154	Taiwan	NT$710.22 Million
Wooshin System KO:017370	Korea	₩240.80 Billion
DPS Resources Bhd KLSE:7198	Malaysia	RM90.39 Million
HC Group Inc STU:HCI	Germany	€1.41 Billion
EYG Gayrimenkul Yatirim Ortakligi A.S. IS:EYGYO	Turkey	TL758.51 Million
KCP Sugar and Industries Corporation Limited NSE:KCPSUGIND	India	Rs-4.60 Billion
Shah Metacorp Limited NSE:SHAH	India	Rs2.57 Billion
Royal Orchid Hotel (Thailand) Public Company Limited BK:ROH	Thailand	฿6.07 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down GenoFocus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See GenoFocus Inc (187420) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.82	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenoFocus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenoFocus Inc (2014–2025)

The table below shows the annual total liabilities of GenoFocus Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩81.08 Billion ≈ $54.95 Million	-33.81%
2024-12-31	₩122.49 Billion ≈ $83.01 Million	+71.31%
2023-12-31	₩71.50 Billion ≈ $48.46 Million	-35.01%
2022-12-31	₩110.02 Billion ≈ $74.56 Million	+32.17%
2021-12-31	₩83.24 Billion ≈ $56.41 Million	+13.32%
2020-12-31	₩73.46 Billion ≈ $49.78 Million	+92.90%
2019-12-31	₩38.08 Billion ≈ $25.81 Million	+276.16%
2018-12-31	₩10.12 Billion ≈ $6.86 Million	+70.65%
2017-12-31	₩5.93 Billion ≈ $4.02 Million	+735.70%
2016-12-31	₩709.87 Million ≈ $481.07K	-3.57%
2015-12-31	₩736.18 Million ≈ $498.90K	-89.89%
2014-12-31	₩7.28 Billion ≈ $4.93 Million	--

About GenoFocus Inc

KQ:187420 Korea Specialty Chemicals

Market Cap

$35.43 Million

₩52.29 Billion KRW

Market Cap Rank

#23282 Global

#1576 in Korea

Share Price

₩1780.00

Change (1 day)

-2.14%

52-Week Range

₩1373.00 - ₩3330.00

All Time High

₩17350.00